The COVID-19 pandemic should prompt bio/pharma facilities to assess how the potential spread of the virus may impact different areas of development and manufacturing facilities, employees, visitors, and product. Learn about strategies for evaluating practices at existing facilities and options for designing new facilities that can accommodate future needs, including flexibility requirements and any emerging threats. Live: Tuesday, May 26, 2020 at 2 pm EDT| 1pm CDT| 11am PDT On demand available after airing until May 26, 2021 Register free
Register free: http://www.pharmtech.com/pt_w/pharma_facilities
Event Overview:
Contamination control has always been a leading concern for bio/pharmaceutical facilities and operations. Facility and HVAC design, process workflows, and standard operating procedures for personnel and equipment are all designed to protect the product and people.
The COVID-19 pandemic requires bio/pharma companies to look beyond good manufacturing practices to assess the how the potential spread of the virus may impact different areas of development and manufacturing facilities, employees, visitors, and product.
In this webcast, experts will review strategies for evaluating practices at existing facilities and will discuss options for designing new facilities that can accommodate future needs, including flexibility requirements and any emerging threats.
Topics include the following:
This Editors’ Series webcast is presented by Pharmaceutical Technology magazine, in conjunction with INTERPHEX.
Speakers: Jason S. Collins, AIA, Director, Process Architecture, IPS
Curt Firestine, Mechanical Engineer, CRB
Time and date: Tuesday, May 26, 2020 at 2 pm EDT| 1pm CDT| 11am PDT
On demand available after airing until May 26, 2021
Sponsors: Contec, DuPont, ILC Dover
Register free: http://www.pharmtech.com/pt_w/pharma_facilities